Auna S.A. (NYSE:AUNA – Get Free Report) Director John Wilton sold 17,574 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the completion of the transaction, the director directly owned 49,974 shares in the company, valued at approximately $208,391.58. The trade was a 26.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Auna Stock Performance
Shares of NYSE AUNA traded up $0.39 during mid-day trading on Monday, hitting $4.54. The stock had a trading volume of 482,885 shares, compared to its average volume of 388,856. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. The company has a 50 day moving average of $5.20 and a two-hundred day moving average of $5.01. Auna S.A. has a twelve month low of $4.09 and a twelve month high of $6.85. The firm has a market cap of $336.01 million, a PE ratio of 17.46 and a beta of 0.82.
Auna (NYSE:AUNA – Get Free Report) last released its earnings results on Friday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.14). Auna had a net margin of 1.53% and a return on equity of 16.25%. The firm had revenue of $336.84 million during the quarter, compared to analyst estimates of $320.54 million. Research analysts predict that Auna S.A. will post 0.81 EPS for the current fiscal year.
Institutional Investors Weigh In On Auna
Analysts Set New Price Targets
Several equities analysts recently issued reports on AUNA shares. Wall Street Zen downgraded Auna from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research downgraded Auna from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. JPMorgan Chase & Co. cut their price target on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research report on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Auna currently has an average rating of “Hold” and a consensus price target of $6.97.
View Our Latest Research Report on Auna
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Featured Articles
- Five stocks we like better than Auna
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
